514 filings
Page 9 of 26
8-K
285gjgig6yxz78rsxj0q
6 May 15
Arqule Reports First Quarter 2015 Financial Results
12:00am
8-K
93giqcu9jazgi4h
4 Mar 15
Results of Operations and Financial Condition
12:00am
8-K
tf0ha 47xwl
12 Nov 14
Arqule Announces Collaboration with Nih for Clinical
12:00am
8-K
m1nc9odlw0yx nv911ha
10 Nov 14
Arqule Announces Positive Top-line Results of Nih- Sponsored Phase 2 Trial of Tivantinib In Prostate Cancer
12:00am
8-K
twbp2mfe8g fv5vbs
10 Nov 14
Arqule Announces Third Quarter Fiscal 2014 Results
12:00am
S-8
ouj66n40vf2 6sl8ql1
23 Sep 14
Registration of securities for employees
12:00am
S-8
lspzw0
23 Sep 14
Registration of securities for employees
12:00am
S-8 POS
r4areyuf hx41kwfgl
23 Sep 14
Registration of securities for employees (post-effective amendment)
12:00am
8-K
g2qmtzm3l6xpurlz fke
5 Aug 14
Arqule Reports Second Quarter 2014 Financial Results
12:00am
8-K
k5uq05n4
30 May 14
Arqule Announces Data Presentations with Tivantinib to Be Featured at Asco 2014
12:00am
8-K
sd94 4q54im
16 May 14
Report of Matters Voted Upon by Stockholders
12:00am
8-K
11c9wpj v2o
7 May 14
Arqule Reports First Quarter 2014 Financial Results
12:00am